Infant milk powder for chyle backflow obstruction

A technology for infant milk powder and barriers, applied in dairy products, milk preparations, applications, etc., can solve problems such as protein intolerance, adverse effects of children returning to normal lifestyles in time, and diet transition that affects effective recovery from diseases, etc. Achieve the effect of improving clinical symptoms and signs and promoting disease recovery

Pending Publication Date: 2017-06-13
李素云
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The nutritional treatment of the disease at home and abroad is mainly based on short-chain fatty acids (MCT) instead of long-chain fatty acids (common cooking oil). For infants and young children who are breast-feeding, MCT oil combined with skimmed milk powder is the main method of feeding. , there has been a lack of standardized nutritional treatment methods and corresponding personalized formula milk
At the same time, diarrhea that cannot be effectively correc

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Infant milk powder for chyle backflow obstruction
  • Infant milk powder for chyle backflow obstruction
  • Infant milk powder for chyle backflow obstruction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] A milk powder for infants with chyloreflux disorder, the content of each component is (g / 100g): lactose 30.0-40.0; maltodextrin 30.0-40.0; fructooligosaccharide 2.0-5.0; phosphatidylseramide peptide 0.005-0.007; MCT 8.0-15.0; EPA0.02-0.03; DHA 0.03-0.04; linolenic acid

[0023] 0.3-0.5; linoleic acid 0.5-0.8; oleic acid 0.1-0.5; arachidonic acid 0.04-0.06; lecithin 0.07-0.08; cephalin 0.08-0.1; taurine 0.03-0.04; Nucleotides 0.02-0.05; Immunoglobulins 0.035-0.065.

Embodiment 2

[0025] A milk powder for infants with chyloreflux disorder, the content of each component is (g / 100g): lactose 30.0-40.0; maltodextrin 30.0-40.0; fructooligosaccharide 2.0-5.0; phosphatidylseramide peptide 0.005-0.007; MCT 8.0-15.0; EPA0.02-0.03; DHA 0.03-0.04; linolenic acid 0.3-0.5; linoleic acid 0.5-0.8; oleic acid 0.1-0.5; arachidonic acid 0.04-0.06; Phospholipid 0.08-0.1; Taurine 0.03-0.04; Inositol 0.015-0.025; Nucleotide 0.02-0.05; Immunoglobulin 0.035-0.065; Vitamin A (200-300)*10 -6 ;Vitamin D (5.0-18.0)*10 －6 ;Vitamin E 0.003.0-0.004;Vitamin K(10.0-15.0)*10 －6 ; Vitamin C 0.03-0.05; Vitamin B 1

[0026] 0.0002-0.0005; Vitamin B 2 0.0002-0.0005; Vitamin B 6 0.0002-0.0005; Vitamin B 12 (0.5-1.0)*10 －6 ; Niacin 0.002-0.004; Folic acid (60.0-100.0)*10 －6 ; Pantothenic acid 0.0015-0.002; Biotin (5.0-10.0)*10 －6 ; Choline 0.1-0.15; Sodium 0.1-0.15; Potassium 0.4-0.5; Copper 0.15-0.2; 0.2; Ca-P ratio

[0027] 2:1; Iodine (80.0-150.0)*10 －6 ; Chlorine 0.3-0.5; Se...

Embodiment 3

[0029]A milk powder for infants with chyloreflux disorder, the content of each component is (g / 100g): lactose 30.0-40.0; maltodextrin 20.0-30.0; fructooligosaccharides 2.0-5.0; short peptide protein 3.0-9.0; Albumin 8.0-12.0; Casein 3.0-5.0; Phosphatidylseramide Peptide 0.005-0.007; MCT 3.0-12.0; EPA 0.02-0.03; DHA 0.03-0.04; Linolenic Acid 0.3-0.5; Acid 0.2-0.6; Arachidonic acid 0.04-0.06; Lecithin 0.07-0.08; Cephalin 0.08-0.1; Taurine 0.03-0.04; Inositol 0.015-0.025; 0.065.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses infant milk powder for chyle backflow obstruction. The infant milk powder comprises carbohydrate, protein and lipid; the carbohydrate comprises fructo-oligosaccharide; the lipid is MCT, EPA, DHA, linolenic acid, linoleic acid, oleic acid, arachidonic acid, lecithin, cephalin, taurine, inositol, nucleotide and immune globulin. The infant milk powder is effective in nutrition support therapy for congenital intestinal lymphangiectasia child patients and is capable of effectively improving the clinical symptoms and signs of the child patients and promoting the disease recovery.

Description

technical field [0001] The invention relates to the field of food for infants and young children, in particular to milk powder for infants with chyle reflux disorder. Background technique [0002] Intestinal lymphangiectasia (IL) is a rare protein-losing enteropathy. It is a kind of expansion and rupture of small intestinal lymphatic vessels caused by various reasons, resulting in protein, fat, immune cells, etc. A rare disorder in which a large amount of material is lost. Clinical manifestations mainly include severe hypoproteinemia, decreased blood lymphocytes, edema, chylous ascites, and diarrhea. The disease is divided into primary and secondary two. Primary small intestinal lymphangiectasia (IL) is caused by congenital abnormalities of thoracic or abdominal lymphatic vessels, that is, hypoplasia, absence, and stenosis of the thoracic duct, mesenteric lymphatic trunk, or chyle pool, etc. Increased, dilated and ruptured, or congenital fissures in intestinal lymphatic v...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23C9/152A23C9/156A23C9/158A23C9/16
CPCA23C9/1522A23C9/1526A23C9/1528A23C9/156A23C9/158A23C9/16
Inventor 李素云刘晓倩贺源吉琳琳李茜玉陈葵
Owner 李素云
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap